Ajit Gill - President & CEO, Nektar Therapeutics

As of March 24, 2006


What is Ajit Gill's Net Worth?

The current estimated net worth of Nektar Therapeutics's President & CEO, Ajit Gill, is estimated to be about $4.24M . Ajit Gill owns about 87,991 units of Nektar Therapeutics common stock. In the last 2 years at Nektar Therapeutics, Ajit Gill has sold an estimated value of $3.81M worth.

What is Ajit Gill's Past Insider Trading?

Ajit Gill's largest purchase order was 100,000 units , worth over $1K on March 8, 2004. Ajit Gill's largest sale order was 50,000 units , worth over $1.1M on March 8, 2004. In total, Ajit Gill has made about 15 transactions over 2 years of their time at Nektar Therapeutics. Ajit Gill usually trades in January, with the busiest year in 2005. The most recent transaction was a sale order of 3,545 units , worth over $69.53K on March 24, 2006.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Ajit Gill's' Mailing Address?

  • Mailing address is C/o Nektar Therapeutic 150 Industrial Road San Carlos CA 94070 CA

What are Nektar Therapeutics's Past Insider Trades?

Nektar Therapeutics's most recent insider trade came on May 17, 2022 by Jonathan Zalevsky who sold 21,673 units worth $85.61K . In the last 19 years, insiders at Nektar Therapeutics have sold an estimated value of $294.28M and bought an estimated value of $84.98M worth of shares. Insider trading is most common in September, with the busiest year in 2017 and 2016. The most active traders at the company are Gil Labrucherie, SVP,  Howard Robin, President & CEO,  and Robert Chess, Director .

NEKTAR THERAPEUTICS Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1